Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Self-assembling complexes for in vivo gene delivery.

J E Hagstrom1

  • 1Mirus Corporation, 505 S Rosa Road, Madison, WI 53719, USA. jimh@genetransfer.com

Current Opinion in Molecular Therapeutics
|March 16, 2001
PubMed
Summary

Developing stable non-viral DNA particles for gene therapy is challenging. Recent advances in understanding in vivo barriers enable rational design of polymer/DNA particles (polyplexes) to resist aggregation and inactivation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recharging cationic DNA complexes with highly charged polyanions for in vitro and in vivo gene delivery.

Gene therapy·2003
Same author

Layer-by-layer deposition of oppositely charged polyelectrolytes on the surface of condensed DNA particles.

Nucleic acids research·1999
Same author

Caged DNA does not aggregate in high ionic strength solutions.

Bioconjugate chemistry·1999
Same author

Quantitative assessment of DNA condensation.

Analytical biochemistry·1999
Same author

Self-assembly of DNA-polymer complexes using template polymerization.

Nucleic acids research·1998
Same author

DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA.

Nature biotechnology·1998

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Nanomedicine

Background:

  • Non-viral DNA particles are promising for gene therapy but face in vivo stability issues.
  • Self-assembling complexes effective in vitro often fail in vivo due to aggregation and inactivation.
  • Understanding in vivo barriers is crucial for developing effective non-viral gene delivery systems.

Purpose of the Study:

  • To review recent advances in overcoming in vivo barriers for non-viral DNA particle formation.
  • To highlight the application of rational design in creating stable polymer/DNA particles (polyplexes).

Main Methods:

  • Review of recent studies employing rational design for polyplex formation.
  • Focus on strategies to prevent in vivo aggregation and inactivation of DNA particles.

Main Results:

  • Significant progress has been made in defining in vivo barriers to stable particle formation.
  • Rational design approaches are yielding polymer/DNA particles with improved in vivo stability.
  • Polyplexes designed to resist aggregation and inactivation show enhanced gene delivery potential.

Conclusions:

  • Rational design, informed by an understanding of in vivo barriers, is key to developing stable non-viral gene delivery vectors.
  • Overcoming aggregation and inactivation is critical for the clinical success of polymer/DNA particles in gene therapy.
  • Continued research in this area promises to advance in vivo gene therapy applications.

Related Experiment Videos